Back to search

Article

Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma

2022-08-19

Abstract excerpt

<h4>Background: </h4> Today, individual prognosis in patients with adenocarcinoma of the esophagus (EAC) is based on post-surgical TNM staging and valid biomarkers are still not implemented. Integrin beta1 (ITGB1) is widely expressed in epithelial cells and promotes cell adhesion and growth. Its impact on tumor progression was described for different tumor entities before, data on its function as biomarker in EAC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a486c452-4b1f-5ed2-b011-990c73373da2
DOI
10.21203/rs.3.rs-1934344/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaDOI 10.21203/rs.3.rs-1934344/v1
Select a neighboring publication to make it the new centre.